²é¿´: 2121  |  »Ø¸´: 9

xiangf

½ð³æ (СÓÐÃûÆø)

[ÇóÖú] NexplanonµÄרÀû°ïæÕÒÕÒ~~~~~~~~~~

Merck¹«Ë¾½üÈÕ±íʾÔÚÃÀ¹úÉÏÊÐ68mgµÄNexplanon (etonogestrel¡¢ÒÀÍÐÔÐÏ©) ƤÏÂÖ²Èë°ôʽ±ÜÔÐÒ©¡£

Õâ¸ö±ÜÔÐÒ©µÄרÀûÕÒ²»µ½£¬Çë¸ßÊÖÃǰï°ï棡£¡
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hnsqwxp

ľ³æ (ÕýʽдÊÖ)

Ò©¼Á¿ÆÑ§¼Ò

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Â¥Ö÷ÊÇÒªÃÀ¹úרÀû»¹ÊÇÖйúרÀû£¬ÊÇ»¯ºÏÎïרÀû»¹ÊÇÖÆ¼ÁרÀûÄØ¡£
2Â¥2011-12-23 15:55:09
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xiangf

½ð³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
Â¥: Originally posted by hnsqwxp at 2011-12-23 15:55:09:
Â¥Ö÷ÊÇÒªÃÀ¹úרÀû»¹ÊÇÖйúרÀû£¬ÊÇ»¯ºÏÎïרÀû»¹ÊÇÖÆ¼ÁרÀûÄØ¡£

ÊÇÕâ¸ö²úÆ·µÄÖÆ¼ÁרÀû£¬¹úÄÚÍâµÄ¶¼¿ÉÒÔ£¬¹úÄÚµÄΪ¼Ñ¡£
лл£¡
3Â¥2011-12-23 16:04:49
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xiangf

½ð³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
Â¥: Originally posted by hnsqwxp at 2011-12-23 15:55:09:
Â¥Ö÷ÊÇÒªÃÀ¹úרÀû»¹ÊÇÖйúרÀû£¬ÊÇ»¯ºÏÎïרÀû»¹ÊÇÖÆ¼ÁרÀûÄØ¡£

ÊÇÕâ¸öÉÌÆ·¶ÔÓ¦µÄÖÆ¼ÁרÀû£¬¾ÍÊÇÕâ¸öƤ·ôÏÂÖ²Èë¼ÁµÄרÀû£¬ÆäËûµÄÖÆ¼Á²»Òª£¬Ð»Ð»£¡
4Â¥2011-12-23 16:05:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hnsqwxp

ľ³æ (ÕýʽдÊÖ)

Ò©¼Á¿ÆÑ§¼Ò

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï
¶¹¸ç(½ð±Ò+2): ¸Ðл²ÎÓë½»Á÷ 2011-12-24 09:24:38
Intrauterine system for retaining and releasing therapeutically effective dose of e.g. biologically active compound within uterus of human for treatment of e.g. menorraghia, has retention elements retaining frame within uterus of mammal
רÀûºÅ: US2010280464-A1   ; WO2010128004-A1  
·¢Ã÷ÈË:        DE GRAAFF W, VEENSTRA H, MARTINE T M T, MULDERS T M T
רÀûȨÈ˺ʹúÂë:ORGANON NV(ORGA-C)
Derwent Ö÷Èë²ØºÅ: 2010-N76468 [79]
±»Éó²éÔ±ÒýÓõÄרÀû: 6       
ÕªÒª: NOVELTY - The system (200) has a deposit i.e. rod-shaped deposit, of a therapeutically effective dose of a biologically active compound. A frame defines an interior space for receipt of the deposit, where the frame has an open structure allowing access to a part of an outer surface of the deposit. Multiple retention elements retain the frame within a uterus of a female mammal. The frame interacts with the deposit to form a mechanical structure having a bending stiffness greater than the sum of that of the frame and deposit taken individually.

USE - Intrauterine system for retaining and releasing a therapeutically effective dose of a biologically active compound within uterus of female mammal i.e. human, for treatment of a medical condition e.g. dysfunctional uterine bleeding, menorraghia, dysmenorrhoea, endometriosis, uterine fibroids, climacteric complaints, osteoporosis and urogenital atrophy (all claimed). Uses include but are not limited to nomegestrol acetate (NOMAc), natural progesterone, levonogestrel, etonogestrel, dydrogesterone, medrogestone, medroxyprogesterone acetate, megestrol acetate, chlormadinone acetate and cyproterone acetate.

ADVANTAGE - The part of the outer surface of the deposit is directly exposed to an environment due to the open structure of the frame, so that the rate controlling effect on a steady state release of the compound to the uterus can be primarily determined by the structure of the deposit and the environment in which the structure is placed, thus enabling relatively easy prediction of release rates within the frame. The flexible frame and the deposit interact to form a composite mechanical structure, so that the system has greater mechanical strength such as bending stiffness, thus achieving an improved structure that ensures adequate strength while ensuring ease of insertion due to the small cross-section of the frame.

Ïêϸ˵Ã÷ - INDEPENDENT CLAIMS are also included for the following:

(1) a method for manufacturing an intrauterine system

(2) a method for treating a female mammal.

¸½Í¼ËµÃ÷ - The drawing shows a perspective view of an intrauterine system prior to assembly.

Intrauterine system (200)

Stem (204)

Frame halves (205, 205')

Living hinges (207, 207')

Snap elements (209)

ÏÔʾÎÄÏ×ÕªÒª
¸½Í¼:

¹ú¼ÊרÀû·ÖÀà:        A61M-037/00; B23P-011/00; A61F-006/00; A61F-006/14; A61K-009/00
µÂÎÂÌØ·ÖÀà´úÂë:        A96 (Medical, dental, veterinary, cosmetic); B07 (General - tablets, dispensers, catheters); B01 (Steroids including systems with rings fused to basic steroid structure); P34 (Sterilising, syringes, electrotherapy); P56 (Machine tools)
µÂÎÂÌØÊÖ¹¤´úÂë:        A11-B07; A12-V03D; B01-C03; B01-C04; B01-C05; B11-C03; B11-C04; B12-M10; B12-M12L; B14-D01B; B14-D01C; B14-F08; B14-H05; B14-N01A; B14-N07; B14-N14; B14-S18
רÀûÏêϸÐÅÏ¢:
רÀûºÅ        ¹«¿ªÈÕÆÚ        Ö÷ IPC        ÖÜ        Ò³Êý        ÓïÖÖ
US2010280464-A1         04 Nov 2010        A61M-037/00        201079         Pages: 11         English
WO2010128004-A1         11 Nov 2010        A61F-006/14        201079                  English
ÉêÇëÏêϸÐÅÏ¢:
US2010280464-A1         US770105         29 Apr 2010
WO2010128004-A1         WOEP055948         03 May 2010
ÓÅÏÈȨÉêÇëÐÅÏ¢ºÍÈÕÆÚ:
EP159353         04 May 2009
Ö¸¶¨¹ú¼Ò (µØÇø)/ÇøÓò:
WO2010128004-A1:
     ¹ú¼Ò (µØÇø): AE; AG; AL; AM; AO; AT; AU; AZ; BA; BB; BG; BH; BR; BW; BY; BZ; CA; CH; CL; CN; CO; CR; CU; CZ; DE; DK; DM; DO; DZ; EC; EE; EG; ES; FI; GB; GD; GE; GH; GM; GT; HN; HR; HU; ID; IL; IN; IS; JP; KE; KG; KM; KN; KP; KR; KZ; LA; LC; LK; LR; LS; LT; LU; LY; MA; MD; ME; MG; MK; MN; MW; MX; MY; MZ; NA; NG; NI; NO; NZ; OM; PE; PG; PH; PL; PT; RO; RS; RU; SC; SD; SE; SG; SK; SL; SM; ST; SV; SY; TH; TJ; TM; TN; TR; TT; TZ; UA; UG; US; UZ; VC; VN; ZA; ZM; ZW
»¯ºÏÎï
DCR ºÅ        ÌØÕ÷ÃèÊö        DCR ºÅ        ÌØÕ÷ÃèÊö        DCR ºÅ        ÌØÕ÷ÃèÊö
102210-1-0-0        (K M)        6478-1-0-0        (K M)        94705-1-0-0        (K M)
13759-2-0-0        (K M)        100334-1-0-0        (K M)        100338-1-0-0        (K M)
100358-1-0-0        (K M)        90738-1-0-0        (K M)        166768-1-0-0        (K M)
102310-2-0-0        (K M)
»·ÏµË÷ÒýºÅ:
10975
Derwent »¯ºÏÎïºÅ:
»¯ºÏÎïºÅ        ÌØÕ÷ÃèÊö        »¯ºÏÎïºÅ        ÌØÕ÷ÃèÊö        »¯ºÏÎïºÅ        ÌØÕ÷ÃèÊö
R19407        (K M)        R00145        (K M)        RA2UMU        (K M)
R15326        (K M)        RA24UQ        (K M)        R00308        (K M)
R12004        (K M)        R01209        (K M)        R01250        (K M)
R04886        (K M)        R13690        (K M)
Derwent ×¢²áºÅ:
×¢²áºÅ        ÌØÕ÷ÃèÊö        ×¢²áºÅ        ÌØÕ÷ÃèÊö        ×¢²áºÅ        ÌØÕ÷ÃèÊö
0145        (S)        0308        (S)        1209        (S)
1250        (S)

Õâ¸öÊÇDII²éµ½µÄÐÅÏ¢£¬£¬woרÀûÀïÖ¸¶¨ÁËCNµÄŶ¡£

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

5Â¥2011-12-23 16:07:28
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hnsqwxp

ľ³æ (ÕýʽдÊÖ)

Ò©¼Á¿ÆÑ§¼Ò

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

Äã×Ðϸ¿´¿´ÊDz»ÊÇÕâ¸ö£¬ÎÒ´ó¸Å¿´ÁËÏÂÃ²ËÆÊÇÕâ¸ö¡£
http://worldwide.espacenet.com/p ... om&locale=en_EP
ÉÏÃæµÄÁ´½ÓÊÇŷר¾ÖÉϵÄͬ×åÐÅÏ¢¡£
6Â¥2011-12-23 16:13:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xiangf

½ð³æ (СÓÐÃûÆø)

ËÍÏÊ»¨Ò»¶ä
ÒýÓûØÌû:
Â¥: Originally posted by hnsqwxp at 2011-12-23 16:07:28:
Intrauterine system for retaining and releasing therapeutically effective dose of e.g. biologically active compound within uterus of human for treatment of e.g. menorraghia, has retention elements  ...

NexplanonÊÇÖ²ÈëÉϱÛÄڲ࣬Æä¿É³ÖÐøµÍÁ¿Îȶ¨µÄÊÍ·ÅÒÀÍÐÔÐÏ©´ïµ½±ÜÔÐ×÷Óá£
ÊÇNexplanon¶ÔÓ¦µÄרÀûŶ£¬Ð»Ð»ÄãµÄÖ§³Ö¡£
7Â¥2011-12-23 16:17:51
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hnsqwxp

ľ³æ (ÕýʽдÊÖ)

Ò©¼Á¿ÆÑ§¼Ò

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

(0)       ±£´æÎª:       ¸ü¶àÑ¡Ïî
Kit for assembling disposable applicator used for inserting implant containing active substance under skin of human or animal, has two components including housing with rod being mountable inside cannula and cannula holder
רÀûºÅ: WO2007082889-A1   ; NO200802754-A ; AU2007206957-A1 ; EP1984063-A1   ; US2009012463-A1   ; KR2008092386-A ; CN101370550-A ; ZA200805243-A ; CA2636145-A1 ; MX2008009009-A1 ; JP2009523515-W ; IN200803712-P4 ; NZ569202-A ; BR200706472-A2
·¢Ã÷ÈË:        BEELEN D C F, VAN HARMELEN M, MOORMANN R T, TAK M P W, MOORMANN R T M, BEELEN D, MOORMANN R, TAK M, HARMELEN M V
רÀûȨÈ˺ʹúÂë:ORGANON NV(ORGA-C)
Derwent Ö÷Èë²ØºÅ: 2007-526746 [39]
±»Éó²éÔ±ÒýÓõÄרÀû: 10       
ÕªÒª: NOVELTY - The kit (1) has a component (4) containing a main housing (5,6) with a handle (7) for grasping and manoeuvring an applicator, a cannula and a cannula holder. The cannula holder is mounted in the main housing that contains an opening for allowing introduction of an implant (3) into its end or an end of cannula. Another component (8) with a housing (9) is provided for closing the opening. The housing is complementary to main housing. A rod (10) is attached to the housing forming an integral region within it. The rod is mountable inside cannula and cannula holder.

USE - For assembling disposable applicator (claimed) used for inserting implant such as rod-like implant, etc., containing active substance under the skin of human or animal. Also for single rod contraceptive implant for releasing substance such as progestogenic hormone e.g. etonogestrel through rod into human body for protection against pregnancy for extended period such as three years.

ADVANTAGE - The risk of damaging the delicate implant during its introduction into the cannula and the cannula holder can be reduced effectively.
¿´ÏÂÕâ¸öרÀû£¬£¬ÉÏÃæµÄÎÒ×Ðϸ¿´ÏÂȷʵ²»ÊÇ£¬Õâ¸öºÃÏñÊÇ¡£
8Â¥2011-12-23 16:28:35
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hnsqwxp

ľ³æ (ÕýʽдÊÖ)

Ò©¼Á¿ÆÑ§¼Ò

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

xiangf(½ð±Ò+10): ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ Ó¦¸ÃÊÇÕâ¸ö£¬Ã»Ïëµ½×îºó¾ÓÈ»ÊǸö×°Öá£ÔÎËÀÁË 2011-12-23 17:12:12
9Â¥2011-12-23 16:43:42
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xiangf

½ð³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
Â¥: Originally posted by hnsqwxp at 2011-12-23 16:43:42:
http://www.soopat.com/Home/Resul ... 50&LeiXing=

ÕæÊÇ̫ǿº·ÁË£¬ÕâÊÇÔõô²éµ½µÄ¡£
10Â¥2011-12-23 17:13:09
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ xiangf µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Çóµ÷¼ÁԺУÐÅÏ¢ +5 CX 330 2026-03-21 5/250 2026-03-22 11:32 by ÑîÑîÑî×Ï
[¿¼ÑÐ] »·¾³Ñ§Ë¶288Çóµ÷¼Á +4 ƤƤƤ123456 2026-03-22 4/200 2026-03-22 11:07 by ÑîÑîÑî×Ï
[¿¼²©] ÕÐÊÕ²©Ê¿1-2ÈË +3 QGZDSYS 2026-03-18 4/200 2026-03-22 10:25 by QGZDSYS
[¿¼ÑÐ] 286·ÖÈ˹¤ÖÇÄÜרҵÇëÇóµ÷¼ÁÔ¸Òâ¿ç¿¼£¡ +4 lemonzzn 2026-03-17 8/400 2026-03-21 22:49 by lemonzzn
[¿¼ÑÐ] 326Çóµ÷¼Á +5 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 8/400 2026-03-21 19:33 by ColorlessPI
[¿¼ÑÐ] 333Çóµ÷¼Á +5 87639 2026-03-21 7/350 2026-03-21 19:31 by ColorlessPI
[¿¼ÑÐ] Çóµ÷¼Á +3 °×QF 2026-03-21 3/150 2026-03-21 13:12 by zhukairuo
[¿¼ÑÐ] 307Çóµ÷¼Á +3 wyyyqx 2026-03-17 3/150 2026-03-21 03:20 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí²ÄÁÏ305·ÖÇóµ÷¼Á +6 ÏëÉϰ¶µÄÀðÓã 2026-03-18 7/350 2026-03-21 01:03 by JourneyLucky
[¿¼ÑÐ] 296Çóµ÷¼Á +6 www_q 2026-03-18 10/500 2026-03-20 23:56 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸Öк£Ñó²ÄÁϹ¤³Ìר˶330·ÖÇóµ÷¼Á +8 С²Ä»¯±¾¿Æ 2026-03-18 8/400 2026-03-20 23:16 by JourneyLucky
[¿¼ÑÐ] Çóµ÷¼ÁÒ»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ289·Ö +3 @taotao 2026-03-19 3/150 2026-03-20 21:34 by JourneyLucky
[¿¼ÑÐ] 353Çóµ÷¼Á +3 À­¹³²»Ðí±ä 2026-03-20 3/150 2026-03-20 19:56 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸Öйúº£Ñó´óѧ£¬ÉúÎïѧ£¬301·Ö£¬Çóµ÷¼Á +5 1ËïÎò¿Õ 2026-03-17 6/300 2026-03-19 23:46 by zcl123
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á +4 18889395102 2026-03-18 4/200 2026-03-19 16:13 by 30660438
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +7 Ϊѧ666 2026-03-16 7/350 2026-03-19 14:48 by ¾¡Ë´Ò¢1
[¿¼ÑÐ] 334Çóµ÷¼Á +3 Ö¾´æ¸ßÔ¶ÒâÔÚ»úÐ 2026-03-16 3/150 2026-03-18 08:34 by lm4875102
[¿¼ÑÐ] 290Çóµ÷¼Á +3 p asserby. 2026-03-15 4/200 2026-03-17 16:35 by wangkm
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄϾ©´óѧ£¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ì£¬µ÷¼Á +4 Jy? 2026-03-16 4/200 2026-03-17 11:02 by gaoqiong
[¿¼ÑÐ] 070303 ×Ü·Ö349Çóµ÷¼Á +3 LJY9966 2026-03-15 5/250 2026-03-16 14:24 by xwxstudy
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û